Vimarsana
Biggest News Aggregation in the World

Page 4 - Omar Ram News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Omar Ram. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Omar Ram Today - Breaking & Trending Today

NJ auto theft up 25% in a year: These cars are stolen most - Vimarsana News

NJ auto theft up 25% in a year: These cars are stolen most

So what are you driving? Would a theft ring be targeting your particular vehicle?

Source: nj1015.com
Happify Health and Almirall Go Live with Digital Solution to Support Psoriasis Patients - Vimarsana News

Happify Health and Almirall Go Live with Digital Solution to Support Psoriasis Patients

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Mayor-elect arrested in Mexico in killing of candidate - Vimarsana News

Mayor-elect arrested in Mexico in killing of candidate

The mayor-elect of a small town in Mexico has been arrested for allegedly masterminding the killing of the candidate he replaced in the June 6 elections…

Almirall receives positive CHMP opinion for Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis - Vimarsana News

Almirall receives positive CHMP opinion for Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis

Almirall receives positive CHMP opinion for Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) of the face or scalp and it acts through a selective antiproliferative mechanism of action The positive opinion is based on the results from two pivotal phase III clinical trials which demonstrated complete clearance of AK lesions at day 57 in treated face or scalp areas in a significantly higher number of patients than with vehicle, together with a...

Almirall and MC2 Therapeutics enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora Cream for treatment of Plaque Psoriasis - Vimarsana News

Almirall and MC2 Therapeutics enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora Cream for treatment of Plaque Psoriasis

(1) In this collaboration Almirall will commercialize Wynzora Cream for treatment of plaque psoriasis in Europe and MC2 Therapeutics will be responsible for manufacturing and supply. MC2 Therapeutics and Almirall partner to make Wynzora Cream a leading topical product for Plaque Psoriasis in Europe In a large European based Phase 3 clinical trial (n=490), Wynzora Cream has demonstrated substantial efficacy with a PGA treatment success of 51% and beneficial treatment convenience 1 Cream has been filed and approval is expected this year Almirall S.A. (BME: ALM), a global biopharmaceutica...